← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2011Last known activity
May 27, 2025
Timeline
2010s
- Jun 1, 2011
Oncovir, Inc.— Founded
Drugs by trial phase (31 distinct, 23 trials)
Phase 2 (18 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Astrocytoma
- Basal Cell Carcinoma
- Carcinoma
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Central Nervous System Neoplasms
- Colonic Neoplasms
- Communicable Diseases
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- HIV Infections
- Infections
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Melanoma
- Mesothelioma
- Neoplasms, Basal Cell
- Oligodendroglioma
- Prostatic Neoplasms
- Recurrence
- Skin Neoplasms
- Squamous Cell Carcinoma of Head and Neck
Recent trials (23)
- NCT06782932CollaboratorPhase 1/Phase 2May 27, 2025
- NCT06064279CollaboratorPhase 1/Phase 2Feb 5, 2024
- NCT06343077CollaboratorPhase 2Jan 16, 2024
- NCT04201873CollaboratorPhase 1Dec 31, 2019
- NCT03835533CollaboratorPhase 1Jun 30, 2019
- NCT03721679Lead sponsorPhase 1/Phase 2Sep 25, 2018
- NCT03219450CollaboratorPhase 1Sep 1, 2018
- NCT03262103CollaboratorPhase 1May 1, 2017
- NCT02950766CollaboratorPhase 1Oct 1, 2016
- NCT02834052CollaboratorPhase 1/Phase 2Jul 1, 2016
- NCT02334735CollaboratorPhase 2Jul 1, 2015
- NCT02423863Lead sponsorPhase 2Mar 1, 2015
- NCT02071095CollaboratorPhase 1/Phase 2Apr 1, 2014
- NCT01984892CollaboratorPhase 2Nov 1, 2013
- NCT01920191CollaboratorPhase 1/Phase 2Aug 1, 2013
Details
- Founded
- Washington, DC, US Jun 1, 2011
- Last known activity
- May 27, 2025